Document is current
Any future updates will be listed below
-
Authors
Cui, Zhicheng https://orcid.org/0000-0003-2398-9344
Esposito, Alessandra https://orcid.org/0000-0002-3838-7242
Napolitano, Gennaro https://orcid.org/0000-0002-8615-4654
Ballabio, Andrea https://orcid.org/0000-0003-1381-4604
Hurley, James H. https://orcid.org/0000-0001-5054-5445
- License Information
-
More Information
Article History
Received: 24 October 2024
Accepted: 18 August 2025
First Online: 17 September 2025
Competing interests
: J.H.H. is a cofounder and shareholder of Casma Therapeutics and receives research funding from Hoffmann-La Roche. A.B. is a cofounder and shareholder of Casma Therapeutics and an advisory board member of Avilar Therapeutics and Amplify Therapeutics. G.N. is an advisory board member of Amplify Therapeutics. The other authors declare no competing interests.
